Vote Scores

Home / Companies / ADC Therapeutics SA / 1 Jun 2026

Meeting · year to 30 June 2026164 filers reporting

ADC Therapeutics SA: meeting of 1 Jun 2026

Votes reported on Form N-PX, item by item

164 Form N-PX filers reported votes at the ADC Therapeutics SA meeting of 1 Jun 2026. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

12 nominees; 95.7% of reported votes for; 11 filers withheld from or voted against at least one nominee.

864 vote records from 52 filers. 1 of the 50 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

94.2% for1.9% against3.8% other2.0% against management52 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

245 vote records from 164 filers. 12 of the 153 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.

86.0% for5.5% against8.5% other7.8% against management164 filers91.9% for1.3% against6.7% other8.1% against management56,426,530 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

77 vote records from 52 filers. 0 of the 50 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

96.2% for0.0% against3.8% other0.0% against management52 filers100.0% for0.0% against0.0% against management11,551,676 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

356 vote records from 51 filers. 41 of the 49 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

13.7% for82.4% against3.9% other83.7% against management51 filers65.9% for34.1% against33.9% against management53,852,347 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

374 vote records from 52 filers. 0 of the 50 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

75.0% for0.0% against25.0% other0.0% against management52 filers80.3% for19.7% against19.6% against management54,681,954 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

345 vote records from 52 filers. 0 of the 50 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

96.2% for0.0% against3.8% other0.0% against management52 filers90.0% for10.0% against10.0% against management76,780,887 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

7 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers77.6% for22.4% against22.4% against management134,610 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalNo reportForNo report
State Street and SPDRForForFor
InvescoNo reportAgainst *No report
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganNo reportForNo report
Goldman SachsForForFor
PGIM and PrudentialNo reportForNo report
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaForForFor
Russell InvestmentsForForFor
NationwideForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonNo reportAgainst *No report
PrincipalSplit or no voteSplit or no voteSplit or no vote
Pacific Life fundsForForFor
Global XForForFor
Federated HermesNo reportForNo report
AllianceBernsteinNo reportForNo report
DWSForForFor
Neuberger BermanNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the ADC Therapeutics SA meeting?

164 Form N-PX filers reported votes at the meeting of 1 Jun 2026. On say-on-pay, 12 of 153 voted against management (7.8%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by ADC Therapeutics SA on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for ADC Therapeutics SA

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing ADC Therapeutics SA with a meeting date within three days of 1 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.